Je was op zoek naar: separationsrelaterede (Deens - Engels)

som en hjælp i behandlingen af hunde med separationsrelaterede problemer i kombination med modificerende opdragelsesteknikker.
as an aid in the treatment of separation-related disorders in combination with behavioural modification techniques.

clomicalm er indiceret som en hjælp i behandlingen af separationsrelaterede problemer i kombination med modificerende opdragelsesteknikker.
clomicalm is indicated as an aid in the treatment of separation-related disorders in combination with behavioural modification techniques.

resultaterne viste, at clomipramin i kombination med modificerende opdragelsesteknikker var effektiv til lindring af symptomer forbundet med separationsrelaterede problemer.
the results showed that clomipramine in combination with behaviour modification techniques was effective in the relief of symptoms related to separation-related disorders.

kliniske afprøvninger har vist at 2-3 måneders behandling med clomicalm i kombination med modificerende opdragelsesteknikker er tilstrækkeligt til at kontrollere symptomerne på separationsrelaterede problemer.
in clinical trials, a treatment time of 2-3 months with clomicalm in combination with behavioural modification techniques was sufficient to control the symptoms of separation-related disorders.

alle hundene fik adfærdsbehandling og blev behandlet med enten reconcile eller med clomipramin, der er et andet lægemiddel, der kan anvendes til at behandle hunde med separationsrelaterede lidelser.
all dogs received behavioural therapy and were treated either with reconcile or with clomipramine (another medicine that can be used to treat dogs with separation-related disorders).

som en hjælp i behandlingen af hunde med separationsrelaterede problemer, som manifesterer sig ved destruktiv adfærd, uønsket elimination (defækation og urinering) og kun i kombination med modificerende opdragelsesteknikker.
as an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate elimination (defaecation and urination) and only in combination with behavioural modification techniques.

udvalget for veterinærlægemidler (cvmp) konkluderede, at fordelene ved clomicalm er større end risiciene, når det anvendes i kombination med adfærdsændrende teknikker som en hjælp i behandlingen af hunde med separationsrelaterede lidelser, og anbefalede udstedelse af markedsføringstilladelse for clomicalm.
the committee for medicinal products for veterinary use (cvmp) concluded that the benefits of clomicalm exceed the risks when used in combination with behavioural modification techniques as an aid in the treatment of dogs with separation-related disorders, and recommended that clomicalm be given a marketing authorisation.